ArticleSAGE open medical case reports2018

Safety and timing of resuming dabigatran after major gastrointestinal bleeding reversed by idarucizumab.

Gian Galeazzo Riario Sforza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.